Recruitment of Atg9 to the preautophagosomal structure by Atg11 is essential for selective autophagy in budding yeast by He, Congcong et al.
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
I
O
L
O
G
Y
JCB: ARTICLE
© The Rockefeller University Press    $8.00
The Journal of Cell Biology, Vol. 175, No. 6, December 18, 2006 925–935
http://www.jcb.org/cgi/doi/10.1083/jcb.200606084
JCB 925
Introduction
As one of the major degradative mechanisms conserved among 
eukaryotic cells, autophagy mediates the turnover and recycling 
of long-lived cytosolic proteins and excess or damaged organ-
elles (Klionsky, 2005). The cargo destined for autophagic degra-
dation is sequestered in a double-membrane vesicle called an 
autophagosome, which fuses with the lysosome in mammalian 
cells or the vacuole in yeast. Eventually, the cargo is degraded by 
lysosomal/vacuolar resident hydrolases. Autophagy occurs in 
response to physiological stress or developmental signals 
(Levine and Klionsky, 2004). Recently, autophagy has been im-
plicated in a variety of human diseases, including cancer, neuro-
degeneration, and pathogen infection (Shintani and Klionsky, 
2004a). The initial identifi  cation  of  >20 autophagy-related 
(ATG) genes in the budding yeast Saccharomyces cerevisiae has 
highlighted this single-cell organism as a perfect model to study 
the molecular mechanism of autophagy, although orthologues of 
some yeast ATG genes have been found in higher eukaryotes.
In yeast, autophagy can be induced under starvation con-
ditions to reuse nutrients for essential cellular activities and 
proper cellular remodeling; this starvation-induced bulk auto-
phagy is considered nonspecifi  c. Studies in yeast have also 
 revealed  that  S. cerevisiae has selective autophagic pathways 
that target specifi  c cargos (Scott et al., 1996; Hutchins et al., 
1999). These pathways mechanistically and genetically resem-
ble bulk autophagy. One such route is the cytoplasm to vacuole 
targeting (Cvt) pathway (Nair and Klionsky, 2005). In this path-
way, two vacuolar hydrolases, the precursor form of aminopep-
tidase I (Ape1 [prApe1]) and α-mannosidase, are transported to 
the vacuole in a double-membrane vesicle called a Cvt vesicle, 
with the former subsequently being processed into mature Ape1. 
Compared with starvation-induced autophagy, the Cvt pathway 
occurs constitutively in growing conditions. Although some Atg 
proteins appear to be pathway specifi  c, most are involved in 
both the specifi  c and nonspecifi  c pathways. However, it is not 
fully understood how these proteins coordinate and function at 
the molecular level in either bulk or selective autophagy.
Most yeast Atg components localize at a perivacuolar 
punctate structure called the preautophagosomal structure 
(PAS) or phagophore assembly site, which is proposed to 
be the site of autophagosome and Cvt vesicle formation 
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(Kim et al., 2002; Noda et al., 2002). In most endomembrane 
traffi  cking systems, such as the early secretory pathway, vesicles 
form by budding from the surface of a preexisting organelle. 
However, in autophagy-related processes, the double-membrane 
sequestering vesicles appear to form de novo; that is, they ex-
pand by membrane addition during the formation process rather 
than being generated from a single piece of contiguous mem-
brane (Reggiori and Klionsky, 2005). One of the major current 
challenges is to unveil where the membrane materials for auto-
phagosomes or Cvt vesicles come from and how the lipids are 
transported to the assembly site. Among all Atg proteins, Atg9 
is the best candidate that can help us understand this pivotal 
  issue. Atg9 is the only characterized integral membrane protein 
required for both autophagosome and Cvt vesicle formation 
(Noda et al., 2000). However, this protein is absent from the 
completed vesicles, suggesting that it is retrieved before the 
vesicle sealing/completion step. Atg9 localizes to multiple 
punctate sites, with one of them corresponding to the PAS and 
others to mitochondria in addition to unidentifi  ed structures 
(Reggiori et al., 2005b). Recent studies reveal that Atg9 cycles 
between mitochondria and the PAS vesicle assembly site 
(Reggiori et al., 2004, 2005b). These characteristics make Atg9 
a potential membrane carrier for vesicle formation.
We decided to investigate the molecular regulatory mech-
anisms underlying Atg9 cycling and, in particular, what factors 
regulate the anterograde transport of Atg9 to the site of vesicle 
formation. In this study, we discovered that a peripheral mem-
brane protein, Atg11 (Kim et al., 2001), is an interaction partner 
of Atg9. The interaction requires the second coiled-coil (CC) 
domain of Atg11 and the Atg9 N-terminal cytosolic domain. 
A missense mutation (H192L) in the Atg9 N-terminal domain 
that disrupts its interaction with Atg11 results in the impaired 
cycling of Atg9 and a defect in selective autophagy. In addition, 
we found that in actin mutant cells, Atg11 colocalized with 
Atg9 and was retained on mitochondria, indicating that Atg11 is 
not able to direct Atg9 to the PAS in the absence of an intact cyto-
skeletal network. These data support a model in which a pool of 
Atg11 links Atg9 to the PAS along the actin cable under vegeta-
tive growth conditions.
Results
Atg11 is an interaction partner of Atg9
Atg9 is the only known transmembrane protein required for 
both bulk autophagy and selective autophagic processes (e.g., 
the Cvt pathway; Noda et al., 2000). Unlike most other Atg pro-
teins, which are restricted to the perivacuolar PAS, Atg9 local-
izes to several punctate structures; one of them is at the PAS, 
whereas the others are primarily confi  ned to mitochondria 
(Reggiori et al., 2005b). Atg9 cycles between the two compart-
ments, suggesting that it plays a role in providing lipids to the 
forming autophagosomes or Cvt vesicles (Reggiori et al., 2004). 
However, other than actin (Reggiori et al., 2005a), the factors 
that regulate the anterograde transport of Atg9 to the PAS have 
not been identifi  ed. Therefore, we performed a yeast two-hybrid–
based screen of Atg proteins to identify potential Atg9-interacting 
proteins. Yeast two-hybrid cells harboring Atg9 and a peripheral 
membrane protein, Atg11, showed robust growth on plates 
  lacking histidine, indicating that Atg11 could interact with Atg9 
(Fig. 1 A). The same result was obtained on plates lacking 
  adenine (unpublished data).
Atg11 functions in selective types of autophagy (i.e., the 
Cvt pathway and pexophagy) but is not essential for bulk 
  autophagy (Kim et al., 2001). Atg11 plays a role in organizing 
the PAS and linking cargo to the vesicle-forming machinery at 
the PAS (Shintani et al., 2002; Yorimitsu and Klionsky, 2005). 
This protein is a component of at least two complexes in yeast. 
One is the Atg1–Atg11 complex, which is involved in the in-
duction of bulk and selective autophagy (Kamada et al., 2000). 
The other is the Atg19–Atg11 complex, which recognizes and 
delivers prApe1 and α-mannosidase to the PAS (Shintani et al., 
2002; Yorimitsu and Klionsky, 2005). We decided to deter-
mine whether these complexes are involved in Atg11 and Atg9 
interaction. To address this issue, we used a biochemical approach 
to examine whether Atg11 was able to form a complex with 
Atg9. We tagged Atg11 with GFP and tagged Atg9 with protein A 
(PA) at the chromosomal locus. Wild-type, atg1∆, and atg19∆ 
Figure 1.  Atg9 interacts with Atg11. (A) A yeast two-hybrid assay reveals 
that full-length Atg9 interacts with full-length Atg11. The two-hybrid strain 
PJ69-4A was cotransformed with plasmids containing the activation do-
main (AD)–fused Atg11 and the binding domain (BD)–fused Atg9 or with 
empty vectors (AD and BD). Interactions were monitored by the ability of 
cells to grow on plates without histidine for 3 d. (B) Atg11 is coprecipitated 
with Atg9 independently of Atg1 and Atg19. Wild-type (TYY161), atg1∆ 
(TYY162), and atg19∆ (CCH005) strains expressing integrated Atg11-
GFP and Atg9–protein A (PA) fusions were used for afﬁ  nity isolation. Wild-
type (WT) strains expressing integrated Atg9-PA alone (FRY171) or 
integrated Atg11-GFP (PSY101) and CUP1 promoter-driven PA (pCuPA(414)) 
were used as controls. Eluted polypeptides were separated by SDS-PAGE 
and detected with anti-YFP antibody. The same amounts of the total lysate 
(T) and immunoafﬁ  nity  puriﬁ   ed isolate (IP) were loaded per gel lane. 
(C) Atg11 is coprecipitated with Atg9 in the absence of Atg23 and Atg27. 
Wild-type (TYY161), atg23∆ (CCH004), and atg23∆ atg27∆ (CCH006) 
strains expressing integrated Atg11-GFP and Atg9-PA fusions were used 
for afﬁ  nity isolation. Total lysates and eluted polypeptides (Aff.Pur.) were 
separated by SDS-PAGE and visualized by immunoblotting with antibody 
to YFP. An Atg11-GFP strain (PSY101) expressing CUP1-driven PA 
(pCuPA(414)) alone was used as a control.ATG11 IS NEEDED FOR ATG9 TRANSPORT • HE ET AL.  927
cells expressing the integrated Atg9-PA and Atg11-GFP fusions 
were lysed, and the PA-tagged protein was isolated with IgG–
Sepharose beads. Atg11 was coprecipitated with Atg9-PA in all 
three strains (Fig. 1 B), which verifi  es that these two proteins 
are present in a complex, although we do not know whether 
they interact directly. Thus, the absence of either Atg1 or Atg19 
did not affect the formation of a complex between Atg9 and 
Atg11. This fi  nding suggests that there might be multiple popu-
lations of Atg11 within the cell that interact with different sets 
of Atg proteins.
Our recent data show that two other Atg proteins, Atg23 
and Atg27, interact with Atg9 and are required for Atg9 cycling. 
The interaction between Atg9 and either Atg23 or Atg27 is not 
mediated through Atg11 (Tucker et al., 2003; and unpublished 
data). Thus, we extended the analysis by determining whether 
the Atg9–Atg11 interaction was dependent on these other Atg9-
interacting proteins. We found that Atg11 was coprecipitated 
with Atg9 in atg23∆ and atg23∆ atg27∆ cells despite a lower 
overall effi  ciency of recovery (Fig. 1 C). This suggests that 
Atg9 and Atg11 were able to form a complex in the absence of 
Atg23 and Atg27, although these two proteins may facilitate the 
interaction. The interaction between Atg9 and Atg11 in the 
atg23∆ or atg27∆ strains was confi  rmed by yeast two-hybrid 
analyses; the atg23∆ or atg27∆ two-hybrid cells expressing 
Atg9 and Atg11 were able to grow on −histidine (−His) selec-
tive plates, which is comparable with the wild-type cells 
(unpublished data).
Atg11 is predicted to contain four CC domains (Fig. 2 A; 
Yorimitsu and Klionsky, 2005). Each CC domain mediates 
  interactions of Atg11 with different Atg proteins. To test 
whether these CC domains are responsible for the interaction 
between Atg11 and Atg9, we used CC domain deletion mu-
tants in a series of yeast two-hybrid assays. As shown in Fig. 
2 B, the two-hybrid mutant activation domain (AD)–Atg11 
C-terminal truncation (11N; ∆627–1,178 and lacking CC3-4) 
allowed the cells to grow in the presence of binding domain 
(BD)–Atg9 as well as the full-length AD-Atg11. In contrast, 
cells expressing an AD-Atg11 N-terminal truncation (11C; 
∆1–817 and lacking CC1-3) could not grow on selective −His 
plates (Fig. 2 B). Thus, the Atg11 N terminus is suffi  cient for 
Atg9–Atg11 interaction. In addition, Atg11∆CC2 (∆536–576) 
abolished the interaction with Atg9, whereas cells containing 
mutants Atg11∆CC1 (∆272–321), Atg11∆CC3 (∆627–858), or 
Atg11∆CC4 (∆859–1,178) grew well on selective plates (Fig. 2 C). 
These data indicated that Atg11 CC domain 2 is required for the 
Atg9–Atg11 interaction.
From a hydropathy plot analysis, Atg9 contains hydro-
philic N and C termini fl  anking six to eight transmembrane 
  domains (Noda et al., 2000). To defi  ne the topology of Atg9, we 
investigated the protease sensitivity of the Atg9 N and C   termini. 
Spheroplasts derived from pep4∆ cells expressing either the 
N-terminal–tagged PA-Atg9 fusion or the C-terminal–tagged 
Atg9-PA fusion were osmotically lysed and centrifuged at 
13,000 g. In agreement with previous studies, approximately two 
thirds of the total Atg9 was present in the S13 supernatant fraction 
that contained the PAS, and one third was present in the P13 pellet 
fraction (Fig. 2 D; Noda et al., 2000; Reggiori et al., 2005b). 
Figure 2.  The Atg9–Atg11 interaction is mediated by the Atg11 CC2 
domain and the Atg9 N-terminal region. (A) Schematic representation of 
Atg11 highlighting the position of the four CC domains and indicating 
the extent of the N- and C-terminal domains used in the two-hybrid analysis. 
(B) The Atg11 N terminus is sufﬁ  cient to interact with Atg9 as demonstrated 
by the yeast two-hybrid assay. Cells expressing an Atg11 N-terminal 
fragment and Atg9 (11N-9), full-length Atg11 and Atg9 (11-9), the 
Atg11 C terminus and Atg9 (11C-9), Atg11 (11), or Atg9 (9) with the 
corresponding empty vector were grown for 3 d on plates lacking 
histidine. (C) Atg11 CC domain 2 is essential for Atg11–Atg9 interaction. 
Cells expressing Atg9 and Atg11 lacking the indicated coiled-coil (CC) 
domains were grown for 3 d on −His plates. (D) Both the N and C 
  termini of Atg9 are protease sensitive. A schematic representation of Atg9 
topology is shown on the left. pep4∆ cells expressing either integrated 
C-terminally tagged Atg9-PA (FRY172) or CUP1-driven N-terminally 
tagged PA-Atg9 (ΤVY1; pCuPAAtg9(416)) were converted to sphero-
plasts and osmotically lysed, and the pellet fraction was subjected to pro-
teinase K (PK) treatment in the presence or absence of Triton X-100 
(TX-100). Fractions were analyzed by immunoblotting with antibodies 
to PA and Pho8. T, total. (E) The Atg9 N terminus interacts with Atg11. 
A schematic diagram of Atg9 and domains used for two-hybrid analysis 
are depicted. Cells expressing Atg11 and the Atg9 N-terminal fragment 
(N), transmembrane domain (TM), C terminus (C), or full-length Atg9 (FL) 
were grown for 3 d on −His plates. (F) Atg9 N-terminal amino acids 
159–255 are the minimal sufﬁ  cient region needed to interact with Atg11. 
A truncation series of the Atg9 N-terminal region in the binding domain 
(BD) two-hybrid plasmid is depicted. The strength of the corresponding 
proteins to interact with activation domain (AD)–Atg11 is indicated on 
the right by the robustness of cell growth on plates without histidine 
(−His) or adenine (−Ade) for 5 d.JCB • VOLUME 175 • NUMBER 6 • 2006  928
When the P13 fraction was treated with exogenous proteinase K, 
both the N- and C-terminal PA tags were cleaved in the ab-
sence or presence of detergent, and no bands of smaller molecu-
lar mass were detected (Fig. 2 D), indicating that both the N and 
C termini of Atg9 were accessible to protease on the cytosolic 
side of the membrane. To verify that intracellular membranous 
structures were intact after osmotic lysis, we simultaneously 
monitored the protease sensitivity of an endogenous vacuole 
membrane protein, Pho8. The precursor form of Pho8 that ac-
cumulated in the pep4∆ background contains a small cytosolic 
tail and a lumenally oriented propeptide (Fig. 2 D). In the ab-
sence of detergent, only the Pho8 cytosolic tail but not the lume-
nal propeptide was accessible to proteinase K. Upon the addition 
of both detergent and proteinase K, the Pho8 lumenal propep-
tide was removed as a result of the disruption of all membra-
nous compartments, which is shown as a further shift of the 
molecular mass (Fig. 2 D). Thus, these data verifi  ed the integ-
rity of the relatively fragile vacuole and presumably other in-
tracellular membranous compartments after osmotic lysis, 
suggesting that both the N and C termini of Atg9 are exposed to 
the cytosol (Fig. 2 D). Accordingly, the topology of Atg9 
 appears  to  be conserved between yeast and mammalian cells 
(Young et al., 2006).
So far, no known functional domains have been identifi  ed 
in the Atg9 N- or C- terminal regions. To further analyze the 
Atg9–Atg11 interaction, we generated truncated Atg9 mutants 
containing the N terminus, C terminus, or transmembrane 
  region. As shown in Fig. 2 E, in the presence of Atg11, the Atg9 
N-terminal domain supported the growth of two-hybrid cells as 
well as the full-length Atg9, whereas neither the C-terminal nor 
the transmembrane domains of Atg9 were able to do so (Fig. 2 E). 
This result showed that Atg11 interacts with the N-terminal re-
gion of Atg9. We further constructed a series of Atg9 N-terminal 
truncation mutants and analyzed them for interaction with 
Atg11 by yeast two-hybrid analysis. Atg9 N-terminal amino 
  acids 159–255 appeared to be the minimal region that mediates 
the interaction with Atg11 (Fig. 2 F). Collectively, we concluded 
that Atg11 and Atg9 interact through the Atg11 CC domain 2 
and the Atg9 N terminus.
Atg11 recruits Atg9 to the PAS
In wild-type cells, Atg11 localizes at the PAS (Kim et al., 2001), 
and Atg9 cycles between the PAS and mitochondria (Reggiori 
et al., 2004, 2005b). To examine the role of the interaction be-
tween Atg9 and Atg11, we analyzed the cycling of Atg9 in the 
presence of overexpressed Atg11 or in the absence of this protein. 
The chromosomally tagged Atg9-YFP chimera displayed a 
multiple punctate distribution in wild-type cells, with one of the 
puncta colocalizing with the PAS marker blue fl  uorescent 
  protein (BFP)–Ape1 (Fig. 3 A). In contrast, in the atg1∆ back-
ground, Atg9 was restricted to the PAS, which is in agreement 
with previous observations that indicated a role for Atg1 in the 
retrograde transport of Atg9 from the PAS to mitochondria 
(Reggiori et al., 2004, 2005a,b). In 91% (109/120) of the cells 
overexpressing Atg11, Atg9-YFP localized solely to the peri-
vacuolar PAS (represented by CFP-Atg11), which is similar to 
the situation observed in atg1∆ cells (Fig. 3 A; Kim et al., 2002), 
and did not localize to mitochondria (not depicted). Thus, ex-
cess Atg11 was able to restrict Atg9 to the PAS. Overexpressed 
Atg11 displays a dominant-negative phenotype, interfering with 
Figure 3.  Atg9 cycles through the PAS in an Atg11-dependent manner. 
(A) Atg11 overexpression restricts Atg9 to the PAS. Wild-type (WT) or 
atg1∆ strains expressing an integrated Atg9-YFP fusion (FRY136 and 
FRY138, respectively) were transformed with a plasmid containing BFP-
Ape1 (pBFPApe1(414)) as the PAS marker. In addition, an atg11∆ strain 
(KTY53) expressing an integrated Atg9-YFP fusion was transformed 
with a centromeric plasmid containing CUP1 promoter-driven CFP-Atg11 
(pCuHACFPCVT9(414)). Cells were grown to mid-log phase and visualized 
by ﬂ   uorescence microscopy. Arrows mark the PAS localization of BFP-
Ape1, and arrowheads mark the sites of colocalization. (B) Atg9 fails to 
transport to the PAS in mutants deleted for Atg11. atg1∆ (FRY138), atg11∆ 
(KTY53), or atg1∆ atg11∆ (YTS150) strains expressing chromosomally 
tagged Atg9-YFP were imaged by ﬂ  uorescence microscopy. (C) The sec-
ond Atg11 CC domain is needed for correct Atg9 cycling. The atg1∆ 
atg11∆ strain (YTS150) was transformed with a plasmid encoding the 
Atg11∆CC1 or Atg11∆CC2 mutants, and YFP ﬂ   uorescence was visual-
ized by ﬂ  uorescence microscopy. In all panels, cells were stained with FM 
4-64 to label the vacuole before being imaged by ﬂ  uorescence microscopy. 
DIC, differential interference contrast. Bar, 2 μm.ATG11 IS NEEDED FOR ATG9 TRANSPORT • HE ET AL.  929
the vacuolar import of prApe1 through the Cvt pathway 
(unpublished data). The dominant-negative phenotype pre-
sumably refl  ects the defect in Atg9 cycling.
To further examine the role of Atg11 in recruiting Atg9 to 
the PAS, we used the TAKA (transport of Atg9 after knocking 
out ATG1) assay (Cheong et al., 2005). This assay examines the 
epistasis of a second mutation relative to atg1∆ with regard to 
Atg9 localization at the PAS. We visualized chromosomally 
tagged Atg9-YFP in atg11∆ single and atg1∆ atg11∆ double 
deletion cells and simultaneously labeled the vacuolar mem-
brane with FM 4-64. As shown previously, in atg1∆ cells, 
Atg9-YFP localized to a single perivacuolar punctum, which 
corresponds to the PAS (Fig. 3 B). In contrast, in nearly 90% of 
the atg11∆ or atg1∆ atg11∆ mutants, Atg9-YFP fl  uorescence 
showed multiple puncta and did not localize at a single peri-
vacuolar structure, suggesting that its anterograde transport 
was blocked because of the ATG11 deletion (Fig. 3 B). These 
results suggest that Atg11 is involved in the anterograde trans-
port of Atg9.
Our mapping of the Atg9 and Atg11 interaction domains 
indicated that Atg11∆CC2 but not Atg11 lacking its other CC 
domains was defective in forming a complex with Atg9 (Fig. 2). 
Accordingly, we examined the effect of Atg11 CC deletions on 
Atg9 subcellular distribution. As shown in Fig. 3 C, in cells ex-
pressing Atg11∆CC1 in the atg1∆ background, Atg9 localized 
to the PAS, which is similar to the result seen in atg1∆ cells 
  expressing wild-type Atg11. In contrast, in cells expressing 
Atg11∆CC2, which lacks the Atg9-interacting domain, Atg9 
displayed a multiple punctate distribution (Fig. 3 C) resembling 
that observed in atg1∆ atg11∆ cells even though the mutant 
protein was expressed at a level similar to the wild-type protein 
(Yorimitsu and Klionsky, 2005). Thus, we concluded that the 
interaction of Atg9 with Atg11 CC domain 2 is required to 
  direct Atg9 to the PAS.
The Atg9
H192L mutant is defective 
for the Cvt pathway
To further clarify the physiological functions of the Atg9–Atg11 
interaction, we decided to test whether autophagic processes 
were affected by its disruption. It has been reported that Atg11 
CC domain 2, the Atg9-interacting domain, interacts with mul-
tiple Atg proteins, including at least one (Atg1) that is involved 
in Atg9 retrograde transport (Yorimitsu and Klionsky, 2005). 
Thus, Atg11∆CC2 may cause pleiotropic effects when used in 
functional studies. To bypass this problem, we decided to use 
native Atg11 and instead to isolate mutations within the Atg9 
N-terminal region that disrupt the interaction with Atg11. We 
performed a PCR-based random mutagenesis on the N-terminal 
region of Atg9 followed by a yeast two-hybrid screen for loss-
of-interaction mutants. A missense mutation was identifi  ed with 
a single histidine to leucine substitution at position 192 (H192L), 
which is located in the minimal region (amino acids 159–255) 
needed for the Atg9–Atg11 interaction (Fig. 2 E). Two-hybrid 
cells harboring this mutation completely lost the capacity for 
growth on selective −adenine (−Ade) plates in the presence of 
Atg11 (Fig. 4 A), whereas the expression level of the mutant 
protein was comparable with that of the wild type (not depicted). 
This indicates that the interaction between Atg9 and Atg11 was 
abolished by the H192L mutation. The loss of Atg9–Atg11 inter-
action was confi  rmed by a coimmunoprecipitation assay. As 
shown in Fig. 4 B, endogenous Atg11 was recovered only with 
wild-type Atg9 but not with the Atg9
H192L mutant. In contrast, 
yeast two-hybrid data indicated that the interaction between 
Atg9 and either Atg2 or Atg18, two proteins involved in the retro-
grade transport of Atg9, was unaffected (unpublished data).
Because both ATG9 and ATG11 are essential genes for the 
Cvt pathway, which is a type of selective autophagy, we moni-
tored the processing of prApe1 as a marker protein for this 
transport route. As shown in Fig. 4 C, cells expressing Atg9
H192L 
did not generate the mature form of Ape1 compared with cells 
expressing wild-type Atg9, indicating that the Cvt pathway was 
impaired by the Atg9 H192L mutation.
Anterograde movement of Atg9
H192L 
is blocked in growing conditions
We were interested in determining whether the impairment of 
the Cvt pathway seen with Atg9
H192L (Fig. 4 B) was caused by 
defects in Atg9 cycling, particularly anterograde movement to 
the PAS. Accordingly, we used the TAKA assay to visualize the 
cycling of Atg9
H192L-GFP in growing conditions and concurr-
ently stained mitochondria with the dye MitoFluor red. In the 
atg1∆ background, wild-type Atg9-GFP was restricted to the 
Figure 4. The  Atg9
H192L mutant is defective for the Cvt pathway. (A) The 
Atg9 H192L mutation disrupts the interaction between Atg9 and Atg11 by 
yeast two-hybrid assay. Cells expressing Atg11 (AD-Atg11) and either the 
empty plasmid (11), the Atg9 N terminus harboring the H192L mutation 
(BD–Atg9N
H192L; 9N
H192L+11), or the wild-type Atg9 N-terminal fragment 
(9N+11) were grown for 5 d on −Ade plates. (B) Atg11 is coprecipitated 
with wild-type Atg9 but not with Atg9
H192L. An atg9∆ strain expressing an 
integrated Atg11-GFP fusion (CCH007) was transformed with a plasmid 
expressing either wild-type Atg9-PA (pAtg9PA(314); Atg9) or Atg9
H192L-PA 
(pAtg9
H192LPA(314); H192L) driven by the Atg9 native promoter. The afﬁ  n-
ity isolation was performed as described in Materials and methods. Eluted 
polypeptides were separated by SDS-PAGE and detected with anti-YFP 
  antibody. A wild-type strain expressing integrated Atg11-GFP and Atg9-PA 
fusions (TYY161) was used as a control (WT). (C) Precursor Ape1 matura-
tion is blocked in cells expressing Atg9
H192L. The atg9∆ strain (JKY007) 
was transformed with a plasmid expressing wild-type Atg9 (pAPG-
9GFP(416)), Atg9
H192L (pAtg9
H192LGFP416; H192L), or an empty vector 
(pRS416; −). Cells were grown to mid-log phase, and protein extracts 
were analyzed by Western blotting using antiserum to Ape1. The positions 
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PAS, as marked with BFP-Ape1 in 94% (116/123) of the cells 
examined (Fig. 5). In contrast, Atg9
H192L-GFP distributed to 
multiple punctate structures in 84% (131/156) of the atg1∆ 
cells, which colocalized, in part, with the mitochondrial label-
ing but not with the PAS. Thus, the Atg9
H192L mutation acted 
epistatically to atg1∆, suggesting that the anterograde move-
ment of Atg9
H192L from mitochondria to the PAS was defective.
Bulk autophagy is not affected 
by disruption of the Atg9–Atg11 interaction
Atg9 is essential for both bulk autophagy and the Cvt pathway, 
whereas Atg11 is required solely in the Cvt pathway (Noda 
et al., 2000; Kim et al., 2001). To clarify whether Atg9 antero-
grade transport via Atg11 is involved in bulk autophagy, we 
used the Atg9
H192L mutant to analyze the progression of bulk 
autophagy by several established assays.
Atg8 conjugated to phosphatidylethanolamine remains as-
sociated with the completed autophagosome and is a marker for 
autophagic delivery to the vacuole (Kirisako et al., 1999, 2000; 
Huang et al., 2000). After delivery of the GFP-tagged Atg8 chi-
mera, the GFP moiety is cleaved and remains relatively stable in 
the vacuole, whereas Atg8 is rapidly degraded. Thus, the accu-
mulation of free GFP refl  ects the progression of bulk autophagy, 
which can be readily detected by Western blotting (Shintani and 
Klionsky, 2004b; Cheong et al., 2005). In atg9∆ cells, essen-
tially no free GFP was detected, indicating that bulk autophagy 
was blocked by ATG9 deletion (Fig. 6 A). In cells expressing 
wild-type Atg9 or Atg9
H192L, free GFP was detectable starting 
2 h after cells were shifted to starvation conditions (synthetic 
medium lacking nitrogen [SD-N]) to induce bulk autophagy, 
although GFP-Atg8 processing showed a delay in Atg9
H192L cells 
compared with wild-type cells. This result demonstrated that 
bulk autophagy retained similar activity even when Atg9 failed 
to interact with the Cvt-specifi  c component Atg11.
To confi  rm the aforementioned result, we quantitatively 
measured bulk autophagy activity using another marker protein, 
Pho8∆60, which encodes an altered form of alkaline phospha-
tase that is only delivered to the vacuole via autophagy (Noda 
et al., 1995). The Pho8∆60 enzymatic activity was measured in 
wild-type and atg1∆ cells and in atg9∆ cells transformed with 
a plasmid expressing wild-type Atg9 or Atg9
H192L or an empty 
vector in growing (synthetic minimal medium [SMD]) and star-
vation (SD-N) conditions (Fig. 6 B). The atg1∆ or atg9∆ cells 
transformed with an empty vector showed only the basal level of 
Pho8∆60 activity after autophagy induction (SD-N), indicating 
that bulk autophagy was defective after deleting either gene. In 
contrast, there was an increase of Pho8∆60 activity in atg9∆ cells 
expressing either wild-type Atg9 or Atg9
H192L, indicating that 
Atg9
H192L rescued the autophagy defect in atg9∆ cells, which is 
comparable with the wild-type Atg9 protein. Collectively, these 
data suggested that bulk autophagy does not depend on the inter-
action between Atg9 and an Atg protein that is needed for antero-
grade movement during specifi  c autophagy (Atg11).
Figure 5.  Anterograde transport of Atg9 to the PAS 
is impaired in the Atg9
H192L mutant under growing 
conditions. The  atg1∆  atg9∆ strain (CCH001) was 
cotransformed with a BFP-Ape1 plasmid (pBF-
PApe1(414)) and a plasmid expressing wild-type 
Atg9-GFP (pAPG9GFP(416)) or Atg9
H192L-GFP 
(pAtg9
H192LGFP(416)). Cells were cultured to mid-log 
phase and stained with MitoFluor red 589 as de-
scribed in Materials and methods before imaging by 
ﬂ  uorescence microscopy. Arrows mark the locations 
of BFP-Ape1. DIC, differential interference contrast. 
Bar, 2 μm.
Figure 6.  Bulk autophagy is normal with the Atg9
H192L mutant. (A) GFP-
Atg8 processing is not affected by Atg9
H192L. The atg9∆ strain (JKY007) 
was cotransformed with a GFP-Atg8 plasmid (pGFPAUT7(414)) and 
a plasmid expressing wild-type Atg9 (pAPG9GFP(416)), Atg9
H192L 
(pAtg9
H192LGFP(416)), or an empty vector (pRS416; atg9∆). Cells were 
grown in SMD to mid-log phase and shifted to starvation conditions 
(SD-N). At the indicated time points, aliquots were taken, and protein ex-
tracts were analyzed by Western blotting using anti-GFP antibody. The 
positions of GFP-Atg8 and free GFP are indicated. The asterisks mark 
nonspeciﬁ  c bands. (B) Pho8∆60 activity is normal in Atg9
H192L-expressing 
cells. The wild-type (WT; YTS158) and atg1∆ (TYY127) strains and the 
atg9∆ strain (CCH002) transformed with a plasmid expressing wild-type 
Atg9 (pAPG9(416)), Atg9
H192L (pAtg9
H192L(416)), or an empty vector 
(pRS416;vec) were grown in SMD to mid-log phase and shifted to SD-N 
for 4 h. The Pho8∆60 activity was measured as described in Materials and 
methods. Error bars indicate the SEM of three independent experiments.ATG11 IS NEEDED FOR ATG9 TRANSPORT • HE ET AL.  931
Atg9
H192L cycling is normal 
during bulk autophagy
Because bulk autophagy activity was not affected by the Atg9 
H192L mutation, it was tempting to speculate that Atg9
H192L 
cycled normally under starvation conditions even though 
it was not capable of forming a complex with Atg11. To test 
this hypothesis, we visualized the movement of Atg9
H192L by 
the TAKA assay after autophagy induction. Cells were treated 
with the drug rapamycin, which mimics starvation conditions 
and induces bulk autophagy. As shown in Fig. 7, in the atg1∆ 
background without rapamycin treatment (−rap), wild-type 
Atg9-GFP was restricted to the PAS, whereas Atg9
H192L-GFP 
could not move to the PAS and displayed a multiple punctate 
localization. After treatment with rapamycin (Fig. 7, +rap), in 
85% (41/48) of the cells, Atg9
H192L-GFP colocalized with the 
PAS marker BFP-Ape1 similarly to wild-type Atg9, indicating 
that Atg9 recruitment to the PAS was normal. Therefore, this 
result demonstrated that during bulk autophagy, the Atg9
H192L 
mutation did not interfere with the cycling of Atg9.
Atg11 localization to the PAS is dependent 
on the actin cytoskeleton
Recently, we have shown that Atg9 anterograde traffi  c to the 
PAS is blocked when the actin cytoskeleton is disrupted by ei-
ther treatment with the drug latrunculin A or point mutations in 
ACT1, the gene encoding actin (Reggiori et al., 2005a). In par-
ticular, the impairment of actin function leads to a defect in the 
Cvt pathway, whereas bulk autophagy is normal; a similar phe-
notype was also observed with the Atg9
H192L mutant. Because 
Atg9 anterograde transport was also dependent on its interaction 
with Atg11 (Fig. 3), we wondered whether there was a func-
tional connection between actin and Atg11 in Atg9 cycling and 
autophagic processes. Previous data show that Atg11 is needed 
to recruit prApe1 to the PAS (Yorimitsu and Klionsky, 2005). 
The atg9-null mutant does not affect the recruitment of prApe1 
to the PAS or the localization of Atg11 (unpublished data), sug-
gesting that Atg11 localization at the PAS is not dependent on 
the Atg9–Atg11 interaction. Thus, we propose that Atg11 medi-
ates actin-dependent Atg9 cycling in the Cvt pathway.
To test this hypothesis, we used an actin mutant, act1-
159, which has defects in actin cable depolymerization, Atg9 
cycling, and the Cvt pathway (Reggiori et al., 2005a). As 
shown in Fig. 8 A, in wild-type cells, GFP-Atg11 localized to 
the PAS as a single punctum; chromosomally tagged Atg9-RFP 
displayed a multiple punctate localization pattern. In the act1-
159 mutant, however, GFP-Atg11 redistributed to cytoplasmic 
patches, which partially colocalized with Atg9-RFP. To re-
veal the identity of these multiple compartments, we stained 
cells with the mitochondrial dye MitoFluor red and the vacu-
olar membrane dye FM 4-64. As shown in Fig. 8 B, in 81% 
(81/100) of the cells, the GFP-Atg11 patches were absent from 
the perivacuolar PAS position; instead, they colocalized with 
the mitochondrial labeling, indicating that Atg11 localized at 
mitochondria when the actin network was defective. Therefore, 
the proper localization of Atg11 to the PAS is dependent on 
the actin cytoskeleton and may underlie the actin-dependent 
Atg9 cycling during the Cvt pathway and other types of spe-
cifi  c autophagy.
Discussion
Atg9 is the only characterized transmembrane protein involved 
in the formation of the sequestering vesicles that form during 
the Cvt pathway, pexophagy, and autophagy. Accordingly, it is 
the best candidate to mark the source of the vesicle membrane. 
Recently, we have shown that Atg9 localizes to mitochondria in 
addition to the PAS, implicating this organelle in supplying 
membrane during autophagy-related processes (Reggiori et al., 
2005b). Only Atg19, which is a receptor for biosynthetic car-
gos, and Atg8 remain associated with the completed vesicles; 
most of the soluble Atg proteins involved in vesicle formation 
presumably dissociate from the membrane before or upon vesi-
cle completion. In contrast, a specifi  c retrieval mechanism oper-
ates in the cycling of Atg9 and the associated protein Atg23 
(Reggiori et al., 2004). The retrograde movement of Atg9 from 
the PAS to mitochondria requires Atg1–Atg13, Atg2, Atg18, 
and the PtdIns3–kinase complex. The transit of Atg9 to the 
PAS involves Atg23, Atg27, and actin (Reggiori et al., 2005a; 
Figure 7.  Anterograde transport of Atg9
H192L 
is normal upon bulk autophagy induction. 
The  atg1∆  atg9∆ strain (CCH001) was 
  cotransformed with a BFP-Ape1 plasmid 
(pBFPApe1(414)) and a plasmid expressing 
wild-type Atg9-GFP (pAPG9GFP(416)) or 
Atg9
H192L-GFP (pAtg9
H192LGFP(416)). Bulk 
autophagy was induced by rapamycin treat-
ment (+rap) as described in Materials and 
methods before imaging by ﬂ  uorescence 
  microscopy. Arrows mark the PAS localiza-
tion of BFP-Ape1. DIC, differential interference 
  contrast. Bar, 2 μm.JCB • VOLUME 175 • NUMBER 6 • 2006  932
Yen et al., 2006; and unpublished data); however, the mecha-
nism by which actin mediates Atg9 movement is not known.
To identify other Atg components involved in the antero-
grade movement of Atg9, we performed a yeast two-hybrid 
screen for proteins that interact with Atg9 and identifi  ed Atg11 
(Fig. 1). This result is intriguing because Atg11 has previously 
been shown to interact with Atg19 and Atg1, which are compo-
nents involved in distinct steps of a specifi  c autophagic process. 
In conjunction with the present result, we propose that Atg11 
acts as a scaffold to coordinate the delivery of multiple compo-
nents, including the cargo–receptor complex, components in-
volved in vesicle formation, and proteins involved in supplying 
membrane, to the site of vesicle formation, the PAS (Fig. 9). 
The Atg11 CC domain2 interacts with the N terminus of Atg9 
(Fig. 2), and the interaction occurs in the absence of Atg1 or 
Atg19 (Fig. 1), suggesting that there are distinct and multiple 
populations of Atg11 within the cell. Atg11 self-interaction 
(Yorimitsu and Klionsky, 2005) may then allow these various 
populations of Atg proteins to be delivered to the PAS in a co-
ordinated manner. Consistent with this model, the overexpression 
of Atg11 restricted Atg9 to the PAS, presumably as a result of 
enhanced delivery (Fig. 3). In contrast, a mutation of H192L 
that disrupts interaction between Atg9 and the specifi  c auto-
phagy component Atg11 resulted in a defect in transporting 
Atg9 to the PAS (Fig. 5). Furthermore, the absence of Atg9 at 
the PAS caused by this point mutation led to a block in the Cvt 
pathway (Fig. 4).
It is known that Atg11 is needed for specifi  c types of auto-
phagy such as the Cvt pathway but is not essential for nonspe-
cifi  c autophagy (Kim et al., 2001). We found that the Atg9 point 
mutant that disrupts the interaction with Atg11 imposed little 
effect on the bulk autophagy induced during starvation (Fig. 6). 
The essentially normal autophagy function was correlated with 
the normal localization/transport of the binding-defective Atg9 
mutant in the presence of the autophagy inducer rapamycin 
(Fig. 7). This fi  nding suggests that the anterograde transport of 
Atg9 during bulk autophagy may be mediated by a different 
mechanism that is at least relatively independent of Atg11. 
Thus, other proteins that may interact with Atg9 deserve further 
investigation to reveal the Atg9 cycling machinery that oper-
ates during bulk autophagy; however, we cannot rule out the 
possibility that a low level of interaction between Atg9
H192L 
and Atg11 allows the anterograde transport of Atg9
H192L after 
autophagy induction.
Finally, we found that actin is required for the localization 
of Atg11 to the PAS (Fig. 8). This observation, coupled with the 
role of Atg11 in Atg9 anterograde movement but not vice versa, 
suggests that Atg11 mediates the connection between actin and 
Atg9 delivery from the mitochondria to the PAS. Actin is not 
needed for bulk autophagy in yeast (Reggiori et al., 2005a), 
which is in agreement with our fi  ndings in the present paper that 
the Atg9
H192L mutant is not defective for nonspecifi  c autophagy. 
It is not known how Atg9 might move along actin cables. The 
third Atg11 CC domain displays some similarity with that of 
Figure 8.  Atg11 localization at the PAS is dependent on the actin cytoskeleton. 
(A) Atg11 alters its distribution in the act1-159 mutant and colocalizes with 
Atg9. Wild-type (WT; FRY245) and act1-159 (IRA004) strains expressing 
an integrated Atg9-RFP fusion were transformed with a plasmid containing 
GFP-Atg11 (pTS495). Cells were grown to mid-log phase at 30°C and 
  imaged by ﬂ  uorescence microscopy. (B) Atg11 is localized to mitochondria 
in the act1-159 mutant. The act1-159 (IRA004) strain was transformed with 
the GFP-Atg11 plasmid. Cells were treated with MitoFluor red 589 or FM 
  4-64 as described in Materials and methods and were imaged by ﬂ  uores-
cence microscopy. DIC, differential interference contrast. Bar, 1 μm.
Figure 9.  Model of Atg9 transport mediated by Atg11. The 
transmembrane protein Atg9 cycles between the PAS and 
  mitochondria. The potential role of Atg9 cycling is to provide 
lipids for vesicle formation in bulk and selective autophagy. In 
the latter, a pool of the peripheral membrane protein Atg11 
along with Atg23 and Atg27 (Reggiori et al., 2005a; Yen 
et al., 2006; and unpublished data) regulates the antero-
grade movement of Atg9 from mitochondria to the PAS, which 
is dependent on actin function. The other two known Atg11 
populations in yeast are indicated: the Atg1–Atg11 complex 
(consisting of Atg1, Atg11, Atg13, Atg17, Atg20, Atg24, 
and Vac8) and the Atg11–Atg19 complex (consisting of 
prApe1, the prApe1 receptor Atg19, and Atg11). The 
  retrieval of Atg9 requires the Atg1–Atg13 complex, Atg2, 
Atg18, and the PtdIns3–kinase complex (not depicted).ATG11 IS NEEDED FOR ATG9 TRANSPORT • HE ET AL.  933
Myo2; however, Atg11 lacks the N-terminal motor domain that 
functions in Myo2 movement (Monastyrska et al., 2006). Thus, 
it is not clear how Atg11 might actually mediate the anterograde 
movement of Atg9. Continued analysis of Atg9 cycling and its 
interactions with Atg11 and other Atg proteins may provide in-
sight into the underlying mechanisms of membrane delivery 
during Cvt vesicle and autophagosome formation.
Materials and methods
Strains, plasmids, and media
The S. cerevisiae strains used in this study are listed in Table I. For gene 
disruption, the entire coding region was replaced by the S. cerevisiae 
TRP1, the Kluyveromyces lactis LEU2 or URA3, the Saccharomyces kluyveri 
HIS3, or the Escherichia coli kan
r gene using PCR primers containing  50 
bases of identity to the regions ﬂ  anking the open reading frame. For PCR-
based integrations of the PA and GFP tags at the 3′ end of the ATG9 and 
ATG11 genes, pHAB102 and pFA6a-GFP-HIS3 were used as templates to 
generate strains expressing fusion proteins under the control of their native 
promoters (Longtine et al., 1998; Abeliovich et al., 2003).
Yeast cells were grown in rich medium (YPD; 1% yeast extract, 2% 
peptone, and 2% glucose) or SMD (0.67% yeast nitrogen base, 2% 
  glucose, amino acids, and vitamins as needed). Starvation experiments 
were conducted in SD-N (0.17% yeast nitrogen base without amino acids 
and 2% glucose).
Plasmids expressing Atg11 truncations (Yorimitsu and Klionsky, 
2005), GFP-Atg8 (pGFP-AUT7(414); Abeliovich et al., 2003), Atg9 
(pAPG9(416); essentially constructed the same as pAPG9(414); Noda 
et al., 2000), Atg9-GFP (pAPG9GFP(416); Noda et al., 2000), and CFP-
Atg11 (pCuHACFPCVT9(414); Kim et al., 2002) have been described 
previously. BFP-Ape1 (pBFPApe1(414)) was constructed by introducing 
BFP (Qbiogene) on a BamHI PCR-generated fragment into a unique BglII 
site situated after the start codon of APE1 (Shintani et al., 2002). GFP-
Atg11 (pTS495) was constructed in a similar manner starting with ATG11 
cloned into the pRS416 vector. PA-Atg9 (pCuPAAtg9(416)) was generated 
by cloning ATG9 into the pRS416-CuProtA vector (Kim et al., 2002). Full-
length Atg9 (pBD-Atg9) and the Atg9 N-terminal (pBD-Atg9N), C-terminal 
(pBD-Atg9C), and transmembrane (pBD-Atg9TM) regions were ampliﬁ  ed 
by PCR from pAPG9(416) and introduced into the two-hybrid vector 
pGBDU-C1 using BamHI and SalI sites. A total of 19 other ATG genes 
were ampliﬁ   ed and cloned into the two-hybrid vector pGAD-C1 using 
BamHI and SalI sites. The serial deletion mutants of the Atg9 N terminus 
were generated by PCR ampliﬁ  cation from pBD-Atg9N and ligated into the 
EcoRI and BamHI sites of pGBDU-C1. The plasmid expressing the Atg9
H192L 
mutant (pAtg9
H192L(416)) was constructed by releasing the ATG9 fragment 
containing H192L from pAtg9
H192LGFP(416) (see Random mutagenesis 
screen…mutant) and was cloned into pAPG9(416) using SacI and AgeI. 
pAtg9PA(314) and pAtg9
H192LPA(314) were constructed by PCR amplify-
ing ATG9 and ATG9
H192L together with its native promoter from pAPG-
9GFP(416) and pAtg9
H192LGFP(416) and incorporating them into 
pNopPA(314) using XhoI and XmaI sites. pNopPA(314) was a gift from 
F. Reggiori (University of Utrecht, Utrecht, Netherlands).
PA afﬁ  nity isolation
Cells were grown to OD600 = 0.8 in SMD, and 100 ml were harvested 
and resuspended in lysis buffer (PBS, 200 mM sorbitol, 1 mM MgCl2, 
0.1% Tween 20, 1 mM PMSF, and protease inhibitor cocktail). The deter-
gent extracts were incubated with IgG–Sepharose beads overnight at 4°C. 
The beads were washed with lysis buffer eight times and eluted in SDS-
PAGE sample buffer by incubating at 55°C for 15 min. The eluates were 
resolved by SDS-PAGE and immunoblotted with anti-YFP antibody.
Random mutagenesis screen and generation of the Atg9 mutant
The gap repair PCR mutagenesis method (Oda et al., 1996) was used to 
generate the Atg11 binding–defective Atg9 mutant. An AvrII site at 942 bp 
Table I. Yeast strains used in this study
Strain Genotype Reference
BY4742 MATα ura3∆ leu2∆ his3∆ lys2∆ Invitrogen
CCH001 SEY6210 atg9∆::HIS5 atg1∆::LEU2 This study
CCH002 YTS158 atg9∆::HIS5 This study
CCH004 TYY161 atg23∆::URA3 This study
CCH005 TYY161 atg19∆::URA3 This study
CCH006 TYY161 atg23∆::URA3 atg27∆::LEU2 This study
CCH007 PSY101 atg9∆::LEU2 This study
DDY1493 MATα ura3-52 leu2-3,112 his3-∆200 tub2-201 act1-159::HIS3 Drubin et al., 1993
FRY136 SEY6210 ATG9-YFP::HIS3 Cheong et al., 2005
FRY138 SEY6210 ATG9-YFP::HIS3 atg1∆::URA3 Reggiori et al., 2004
FRY171 SEY6210 ATG9-PA::TRP1 This study
FRY172 SEY6210 ATG9-PA::TRP1 pep4∆::LEU2 Reggiori et al., 2004
FRY245 SEY6210 ATG9-RFP::HIS3 Reggiori et al., 2005b
IRA004 DDY1493 ATG9-RFP::KAN Reggiori et al., 2005b
JKY007 SEY6210 atg9∆::HIS3 Noda et al., 2000
JLY87 PJ69-4A atg23∆::KAN J.  Unpublished data
JLY88 PJ69-4A atg27∆::KAN Unpublished data
KTY53 SEY6210 ATG9-YFP::HIS3 atg11∆::URA3 Reggiori et al., 2004
PJ69-4A MATα leu2-3,112 trp1-∆901 ura3-52 his3-∆200 gal4∆ gal80∆ 
  LYS2::GAL1-HIS3 GAL2-ADE2 met2::GAL7-lacZ
James et al., 1996
PSY101 SEY6210 ATG11-GFP::HIS3 This study
SEY6210 MATα ura3-52 leu2-3,112 his3-∆200 trp1-∆901 lys2-801 
 suc2-∆9 mel GAL
Robinson et al., 1988
TVY1 SEY6210 pep4∆::LEU2 Gerhardt et al., 1998
TYY127 YTS158 atg1∆::HIS5 This study
TYY161 SEY6210 ATG11-GFP::HIS3 ATG9-PA::TRP1 This study
TYY162 TYY161 atg1∆::URA3 This study
YTS150 SEY6210 ATG9-YFP::HIS5 atg1∆::URA3 atg11∆::LEU2 Shintani and Klionsky, 2004b
YTS158 BY4742 pho8::pho8∆60 pho13∆::KAN This studyJCB • VOLUME 175 • NUMBER 6 • 2006  934
was introduced into the pAPG9GFP(416) plasmid by site-directed 
  mutagenesis. The Atg9 N-terminal region containing the AvrII site was ampli-
ﬁ  ed and introduced into pGBDU-C1 with EcoRI and BamHI to generate 
pBD-Atg9N(AvrII). A gapped pGBDU-C1 plasmid was generated by di-
gesting with EcoRI and BamHI. The PCR reaction was performed using 
Taq polymerase (New England Biolabs, Inc.) with pBD-Atg9N(AvrII) as 
the template. The dATP concentration was lowered to three ﬁ  fths that of 
the other three deoxynucleoside triphosphates. The resulting mutagenized 
PCR product shares overlapping sequences of  100 bp at both 5′ and 
3′ ends with the gapped pGBDU-C1 plasmid. The PCR product and the 
gapped plasmid were cotransformed into the two-hybrid strain PJ69-4A. 
The transformants were replicated on both −His and −Ade plates. The 
transformants that were not able to grow on either plate were selected 
and analyzed by Western blotting for protein stability using anti-Atg9 an-
tiserum (Noda et al., 2000). Stable mutants were sequenced, and pBD-
Atg9N
H192L was identiﬁ  ed. The Atg9 N-terminal fragment containing the 
H192L mutation was then released from pBD-Atg9N
H192L by digestion at 
the introduced AvrII site and a natural NruI site. This fragment was cloned 
into pAPG9GFP(416) digested with the same restriction enzymes to generate 
pAtg9
H192LGFP(416).
Fluorescence microscopy
Cells expressing fusion proteins with ﬂ  uorescence tags were grown in SMD 
media to OD600 = 0.8. For vacuolar membrane labeling, cells were pelle-
ted, resuspended in fresh media at OD600 = 1.0, incubated with 2 μM FM 
4-64 at 30°C for 15 min, and pelleted and cultured in the same media 
without FM 4-64 at 30°C for 30 min. For mitochondrial ﬂ  uorescent label-
ing, MitoFluor red 589 (Invitrogen) was added to the growing culture at a 
ﬁ  nal concentration of 1 μM, and the culture was incubated at 30°C for 
30 min. Cells were then washed with the same culture medium before im-
aging to remove the excess dye. For rapamycin treatment, cells were cul-
tured with 0.2 μg/ml rapamycin at 30°C for 1.5 h. When necessary, a 
mild ﬁ  xation procedure was applied to visualize Atg9 without destroying 
various ﬂ  uorescent proteins: cells were harvested, resuspended in a half 
volume of ﬁ  xation buffer (50 mM KH2PO4, pH 8.0, 1.5% formaldehyde, 
and 1 μM MgCl2), and incubated at room temperature for 30 min with 
gentle shaking. Cells were then washed once with an equal amount of 
wash buffer (50 mM potassium phosphate, pH 8.0, and 1 μM MgCl2) and 
resuspended in 50 μl of wash buffer. Fluorescence signals were visualized 
on a ﬂ  uorescence microscope (IX71; Olympus). The images were captured 
by a camera (Photometrics CoolSNAP HQ; Roper Scientiﬁ  c) and decon-
volved using DeltaVision software (Applied Precision).
Additional assays
The GFP-Atg8 processing assay, the Pho8∆60 activity assay, and the 
  protease protection assay were performed as previously described (Noda 
et al., 1995; Wang et al., 2001; Abeliovich et al., 2003; Shintani and 
Klionsky, 2004b; Cheong et al., 2005).
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